| Name | Title | Contact Details |
|---|
At Goodwater, we empower exceptional entrepreneurs everywhere to change the world for good. We believe consumer technology is the most powerful force on earth, shaping culture and transforming the global economy at unprecedented speed and scale. We invest in the worlds most promising entrepreneurs to solve the worlds most pressing problems. As a combined force, Goodwater companies are a global force for change, poised to measurably improve billions of lives. Learn more at www.goodwatercap.com
Under The Radar is a Chicago, IL-based company in the Business Services sector.
central printing co is a Beckley, WV-based company in the Business Services sector.
Evanston Capital is an alternative investment management firm located in Illinois, specializing in multi-manager hedge fund strategies. Founded by four partners, including a former CIO of the Northwestern University Endowment, the firm has over 20 years of experience and manages approximately $4.1 billion in assets as of April 2025. The company creates versatile hedge fund portfolios tailored to meet the needs of sophisticated institutions and high net worth families. Their offerings include core multi-strategy portfolios, concentrated low-beta strategies, credit strategies, and partnerships with specialist managers. Evanston Capital also provides custom solutions for institutional and accredited investors, focusing on achieving attractive risk-adjusted returns. Additionally, the firm is involved in private equity and venture capital strategies, including blockchain ventures.
Braeburn Inc., also known as Braeburn Pharmaceuticals, is a biopharmaceutical company dedicated to developing and commercializing innovative long-acting implantable and injectable medications. The company primarily focuses on treatments for opioid use disorder (OUD) and other central nervous system (CNS) disorders, including pain, schizophrenia, and spasticity. Braeburns product portfolio features advanced delivery technologies such as ProNeura, FluidCrystal, and MedLaunch. Notable products include Probuphine, a six-month implantable treatment for opioid addiction, and CAM2038, which offers weekly and monthly buprenorphine formulations. The company is committed to addressing unmet needs in specialty CNS markets and emphasizes community engagement and patient-centered insights to support recovery. Braeburn aims to establish long-acting treatment options as standards of care while fostering a culture of diversity, equity, and inclusion.